Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease

Alessia Lodi^*, Stefano Tiziani, Farhat L. Khanim, Ulrich L. Günther, Mark R. Viant, Gareth J. Morgan, Christopher M. Bunce, Mark T. Drayson

^*Korrespondierende/r Autor/-in für diese Arbeit